表紙
市場調查報告書

PCR市場:qPCR,dPCR,單基因偵測,多基因偵測市場:執行、顧問指南,客製化預測與分析(2020∼2024年)

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024

出版商 Howe Sound Research 商品編碼 854116
出版日期 內容資訊 英文 276 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
PCR市場:qPCR,dPCR,單基因偵測,多基因偵測市場:執行、顧問指南,客製化預測與分析(2020∼2024年) PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024
出版日期: 2019年06月03日內容資訊: 英文 276 Pages
簡介

單基因偵測檢驗是否會過時,日常癌症檢驗還是否能實現,家庭醫生和家庭診斷是否能實現,數字PCR會成為新的實驗室標準嗎?

本報告提供全球PCR市場相關調查,市場現狀及未來趨勢,成長的機會,各地區趨勢,以及加入此市場的主要企業簡介等相關資訊彙整。

市場指南

第1章 簡介和市場定義

  • 所謂PCR技術
  • PCR:新地平線
  • 市場定義
  • 調查方法
  • 美國醫療市場與實驗室檢驗:展望

第2章 PCR技術的指南

  • PCR
  • 概念
  • 應用
  • PCR:優點與缺點
  • 各種PCR

第3章 產業概要

  • 市場參與企業

第4章 市場趨勢

  • 促進成長要素
  • 阻礙成長要素
  • 治療技術開發

第5章 PCR近幾年的發展

第6章 PCR企業簡介

第7章 PCR市場

  • 各國市場概要

第8章 全球PCR市場:各用途

  • 概要
  • 臨床多基因偵測
  • 臨床單基因偵測
  • 研究
  • 法醫學
  • 其他

第9章 各技術市場

  • 概要
  • qPCR
  • dPCR
  • 其他

附錄

目錄

“PCR Markets Enter Digital Age Poised to Dominate Diagnostic Markets...“

OVERVIEW:

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1. What are PCR Technologies?
  • 1.2. PCR - New Horizons
    • 1.2.1. PCR and Syndromic Testing
  • 1.3. Market Definition
    • 1.3.1. Market Size
    • 1.3.2. Currency
    • 1.3.3. Years
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. PCR - Guide to PCR Technologies

  • 2.0. PCR
  • 2.1. Concepts
    • 2.1.1. Method
  • 2.2. Applications
    • 2.2.1. Finding Specific DNA
    • 2.2.2. Measuring DNA
    • 2.2.3. Medical and diagnostic applications
      • 2.2.3.1. Carrier, prenatal and tissue typing
      • 2.2.3.2. Cancer Diagnosis and Management
      • 2.2.3.3. Infectious disease - New Levels of Accuracy and Sensitivity
      • 2.2.3.4. Forensic applications
      • 2.2.3.5. Science and Research
  • 2.3. PCR - Advantages and Disadvantages
  • 2.4. Different Types of PCR
    • 2.4.1. Simple Changes
      • 2.4.1.1. Multiplex-PCR
      • 2.4.1.2. VNTR PCR
      • 2.4.1.3. Asymmetric PCR
      • 2.4.1.4. Long PCR
      • 2.4.1.5. Nested PCR
      • 2.4.1.6. Quantitative PCR
      • 2.4.1.7. Hot-start PCR
      • 2.4.1.8. Touchdown PCR
      • 2.4.1.9. Assembly PCR
      • 2.4.1.10. Colony PCR
      • 2.4.1.11. Suicide PCR
      • 2.4.1.12. Cold PCR
    • 2.4.2. Digital PCR
      • 2.4.2.1. Droplet Digital PCR
      • 2.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 2.4.2.3. Digital PCR in Use
      • 2.4.2.4. Digital PCR Commercial History
    • 2.4.3. Isothermal PCR

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Genomic Instrumentation Supplier
      • 3.1.3.1. Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4. Pharmaceutical/Reagent Supplier
    • 3.1.5. Independent Testing Lab
    • 3.1.6. Public National/regional lab
    • 3.1.7. Hospital lab
    • 3.1.8. Physician Lab
    • 3.1.9. Audit Body
    • 3.1.10. Certification Body

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Standard
    • 4.1.2. Down the Curve We Go
    • 4.1.3. Multiplexing
    • 4.1.4. Syndromic Diagnostics Looks Unstoppable
    • 4.1.5. The Genetic Blizzard
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Cost Curve
    • 4.2.2. The Other Guys
    • 4.2.3. Systemic Roadblocks
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Instrumentation Curve
    • 4.3.2. Shifting Role of Diagnostics
    • 4.3.3. Diagnostics Moves Out of the Lab
      • 4.3.3.1. What About Imaging?
    • 4.3.4. Disruption Looms
    • 4.3.5. The Next Five Years

5. PCR Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
      • QIAGEN Plans for Next-Generation Digital PCR Systems
      • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
      • New PCR Technology: Transfer-PCR (tPCR) Applications
      • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
      • Natera Applies Massively Multiplexed PCR to Kidney Transplants
      • Paragon Genomics, MGI Tech Form Distribution Alliance
      • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
      • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
      • Bruker to Acquire Majority in Hain Lifescience GmbH
      • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
      • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
      • PredictImmune Wins £100K Grant for Study of IBD Prognostic
      • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
      • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
      • Bio-Rad Wins USDA Food Safety Testing Contract
      • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets

  • 7.1. PCR - Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country

8. Global PCR Markets - By Application

  • 8.1. Global Market by Application - Overview
    • 8.1.1. Table - Global Market by Application
    • 8.1.2. Chart - Global Market by Application - 2019/2024 Comparison
    • 8.1.3. Chart - Global Market by Application - 2019
    • 8.1.4. Chart - Global Market by Application -2024
    • 8.1.4. Chart - Global Market by Application - Share by Year
  • 8.2. PCR Clinical Multiplex
    • 8.2.1. Table PCR Clinical Multiplex Testing - by Country
    • 8.2.2. Chart - PCR Clinical Multiplex Testing Growth
  • 8.3. PCR Clinical Singleplex
    • 8.3.1. Table PCR Clinical Singleplex Testing - by Country
    • 8.3.2. Chart - PCR Clinical Singleplex Testing Growth
  • 8.4. PCR Research
    • 8.4.1. Table PCR Research - by Country
    • 8.4.2. Chart - PCR Research Growth
  • 8.5. PCR Forensic
    • 8.5.1. Table PCR Forensic - by Country
    • 8.5.2. Chart - PCR Forensic Growth
  • 8.6. PCR Other
    • 8.6.1. Table PCR Other - by Country
    • 8.6.2. Chart - PCR Other Growth

9. Global PCR Markets - By Technology

  • 9.1. Global Market by Technology - Overview
    • 9.1.1. Table - Global Market by Technology
    • 9.1.2. Chart - Global Market by Technology - 2019/2024 Comparison
    • 9.1.3. Chart - Global Market by Technology - 2019
    • 9.1.4. Chart - Global Market by Technology -2024
    • 9.1.4. Chart - Global Market by Technology - Share by Year
  • 9.2. qPCR
    • 9.2.1. Table qPCR - by Country
    • 9.2.2. Chart - qPCR Growth
  • 9.3. dPCR
    • 9.3.1. Table dPCR - by Country
    • 9.3.2. Chart - dPCR Growth
  • 9.4. Other PCR
    • 9.4.1. Table Other PCR - by Country
    • 9.4.2. Chart - Other PCR Growth

Appendices

  • I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule - National Limit and Midpoint
  • II. FDA Approved Microbial Tests

Table of Tables

  • TABLE 1: List of Cancers by Mortality
  • TABLE 2: Lab Spending 2014 to 2024
  • TABLE 3: Market Players by Type
  • TABLE 4: Five Factors Driving Growth
  • TABLE 5: Three Factors Limiting Growth
  • TABLE 6: GLOBAL PCR MARKET BY REGION
  • TABLE 7: GLOBAL MARKET BY APPLICATION
  • TABLE 8: PCR CLINICAL MULTIPLEX BY COUNTRY
  • TABLE 9: PCR CLINICAL SINGLEPLEX BY COUNTRY
  • TABLE 10: PCR RESEARCH BY COUNTRY
  • TABLE 11: PCR FORENSIC BY COUNTRY
  • TABLE 12: PCR OTHER BY COUNTRY
  • TABLE 13: GLOBAL MARKET BY TECHNOLOGY
  • TABLE 14: QPCR BY COUNTRY
  • TABLE 15: DPCR BY COUNTRY
  • TABLE 16: OTHER PCR BY COUNTRY
  • TABLE 17: 2018 Clinical Lab Fee Schedule

Table of Figures

  • FIGURE 1: Cancer Death Rates - USA, CDC
  • FIGURE 2: Clinical Lab Spending 2014 to 2024
  • FIGURE 3: The PCR Process
  • FIGURE 4: Creation of Sample Droplets for Digital PCR
  • FIGURE 5: Comparing Syndromic and Targeted Testing
  • FIGURE 6: Comparing The New Diagnostics and Traditional Testing
  • FIGURE 7: Growth rates of DiagnosticTechnologies
  • FIGURE 8: 2018 Global Market Density Chart
  • FIGURE 9: PCR Market by Application - 2019 vs. 2024
  • FIGURE 10: PCR MARKET 2019
  • FIGURE 11: PCR MARKET 2024
  • FIGURE 12: APPLICATION SHARE BY YEAR
  • FIGURE 13: PCR CLINICAL MULTIPLEX TESTING GROWTH
  • FIGURE 14: PCR CLINICAL SINGLEPLEX TESTING GROWTH
  • FIGURE 15: PCR RESEARCH GROWTH
  • FIGURE 16: PCR FORENSIC GROWTH
  • FIGURE 17: PCR OTHER GROWTH
  • FIGURE 18: PCR MARKET BY TECHNOLOGY - 2019 VS. 2024
  • FIGURE 19: PCR MARKET 2019
  • FIGURE 20: PCR MARKET 2024
  • FIGURE 21: TECHNOLOGY SHARE BY YEAR
  • FIGURE 22: QPCR GROWTH
  • FIGURE 23: DPCR GROWTH
  • FIGURE 24: OTHER PCR GROWTH
Back to Top